Two of the hottest names in health wearables — Oura, maker of the smart ring, and Whoop, known for its fitness tracker — are eyeing initial public offerings at what the Wall Street Journal describes as "heady valuations." The push comes as consumer appetite for devices that monitor everything from sleep scores to heart rate shows no signs of slowing.
But according to the Wall Street Journal's David Wainer, investors are approaching the sector with real caution. The hesitation traces back to hard lessons learned from Fitbit, whose post-IPO struggles became a cautionary tale for the industry. Beyond that one example, the broader concern is structural: consumer hardware businesses tend to operate on thin margins, making it difficult to justify the kind of premium valuations that software companies routinely command.
The tension at the heart of this story is whether Oura and Whoop can convince public market investors that they are something more than gadget makers — perhaps platforms with recurring subscription revenue or health data assets that set them apart from a typical hardware play.
It matters because the outcome could define how Wall Street values the next wave of health technology companies, setting a benchmark for an entire sector sitting at the intersection of consumer electronics and healthcare.